Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston
boston blog main
boston top stories
life sciences
muscular dystrophy
2
×
national blog main
national top stories
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biopharma
bluebird bio
clinical trials
deals
duchenne
duchenne muscular dystrophy
dyne therapeutics
europe blog main
europe top stories
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
licensing
m&a
myotonic dystrophy type 1
new york blog main
rare disease drugs
roche
romesh subramanian
san diego blog main
san francisco blog main
sarepta therapeutics
susanna high
vertex pharmaceuticals
What
therapeutics
ago
approval
betting
billion
biopharma
biotechs
considering
data
deal
diseases
drug
duchenne
dyne
early
expected
experimental
eyes
fda
gene
genetic
having
historic
humans
ipo
ipos
long
medicine
medicines
muscle
puts
rare
reach
recently
rna
roche
sarepta
second
swiss
therapy
Language
unset
Current search:
biotech
×
" muscular dystrophy "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal